Comparison of Airtraq Video Laryngoscope Use in Class 2-3 Obese and Non-Obese Men During Intubation

What this Trial Is About

Morbid obesity is a growing health concern, and intubating patients with this condition can be challenging, especially for men. This study evaluates the use of a new video laryngoscope called Airtraq during intubation in morbidly obese men compared to non-obese men. The goal is to compare the time needed for intubation and related factors between these two groups in a prospective randomized setting. Participants will be divided into two groups: men with class 2-3 obesity (BMI over 35) and non-obese men (BMI under 30). Both groups will undergo intubation using the Airtraq video laryngoscope device. The primary focus is on measuring the intubation time, while secondary measures include insertion time, need for optimization maneuvers, perioperative hemodynamic variables, and monitoring for postoperative complications. During the study, researchers will record the intubation and insertion times, monitor the participants' vital signs for four hours during surgery, and note any complications after the procedure. The study is randomized and double-blinded to ensure unbiased results. Participation involves elective operations requiring intubation and careful monitoring throughout the perioperative period, with the total study duration varying by individual.

Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study